€ million |
Jan – Sep |
Jan – Sep |
||
---|---|---|---|---|
|
||||
Income |
2,459 |
2,972 |
||
Depreciation, amortization, impairment losses, write-backs |
1,612 |
1,746 |
||
Changes in provisions |
–123 |
–236 |
||
Deferred taxes / non-cash income and expenses / income from disposal of non-current assets and marketable securities |
1,577 |
111 |
||
Changes in working capital |
–1,176 |
208 |
||
Cash flows from operating activities of continuing operations |
4,349 |
4,801 |
||
Cash flows from operating activities of discontinued operations |
288 |
|
||
Cash flows from operating activities |
4,637 |
4,801 |
||
|
|
|
||
Capital expenditure on non-current assets |
–3,339 |
–2,492 |
||
Proceeds from disposal of assets / divestitures |
1,091 |
864 |
||
Changes in marketable securities and cash investments |
3,909 |
–1,018 |
||
Cash flows from investing activities of continuing operations |
1,661 |
–2,646 |
||
Cash flows from investing activities of discontinued operations |
–487 |
|
||
Cash flows from investing activities |
1,174 |
–2,646 |
||
|
|
|
||
Cash flows from financing activities of continuing operations |
–5,387 |
–2,524 |
||
Cash flows from financing activities of discontinued operations |
195 |
|
||
Cash flows from financing activities |
–5,192 |
–2,524 |
||
|
|
|
||
Net cash change in cash and cash equivalents |
619 |
–369 |
||
Effect of changes in foreign exchange rates and other changes in value on cash and cash equivalents |
4 |
–11 |
||
Net cash change in cash and cash equivalents from discontinued operations |
4 |
|
||
Net change in cash and cash equivalents |
627 |
–380 |
||
Cash and cash equivalents at beginning of reporting period |
1,922 |
2,794 |
||
Cash and cash equivalents at end of reporting period |
2,549 |
2,414 |
History